Apotransferrin in Patients With β-thalassemia

NCT03993613 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped no availability of IMP for this study

Conditions

β-thalassemia Intermedia

Interventions

BIOLOGICAL: human apotransferrin

Sponsor

Prothya Biosolutions